Dear Healthcare Professionals,

On this website we would like to inform you about the COMPETE phase III clinical trial for treatment of neuroendocrine tumors of gastroenteric or pancreatic origin (GEP-NET). Here, you will find extensive pertinent information about the study’s design, inclusion and exclusion criteria, participating clinical centers, the therapy agent, and more.

Your COMPETE Team